Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion

Abstract

Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor contributing to opiate abuse1,2. Increased noradrenaline in the brain has long been implicated in opiate withdrawal3, but it has not been clear which noradrenergic systems are involved. Here we show that microinjection of β-noradrenergic-receptor antagonists, or of an α2-receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly attenuates opiate-withdrawal-induced conditioned place aversion. Immunohistochemical studies revealed that numerous BNST-projecting cells in the A1 and A2 noradrenergic cell groups of the caudal medulla were activated during withdrawal. Lesion of these ascending medullary projections also greatly reduced opiate-withdrawal-induced place aversion, whereas lesion of locus coeruleus noradrenergic projections had no effect on opiate-withdrawal behaviour. We conclude that noradrenergic inputs to the BNST from the caudal medulla are critically involved in the aversiveness of opiate withdrawal.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Noradrenergic afferents to the BNST are stimulated by opiate withdrawal.
Figure 2: Effects of dorsal (DNAB) and ventral (VNAB) noradrenergic bundle lesions on aversive and somatic signs of opiate withdrawal.
Figure 3: Effects of infusing noradrenergic drugs into the BNST on conditioned place aversion and somatic signs of opiate withdrawal.
Figure 4: Locations of injection sites.

Similar content being viewed by others

References

  1. Bechara, A., Nader, K. & van der Kooy, D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol. Biochem. Behav. 59, 1–17 (1998).

    Article  CAS  Google Scholar 

  2. O'Brien, C. P., Childress, A. R., McLellan, A., Ehrman, R. & Ternes, J. Types of conditioning found in drug-dependent humans. NIDA Res. Monogr. 84, 44– 61 (1988).

    CAS  PubMed  Google Scholar 

  3. Maldonado, R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21, 91–104 ( 1997).

    Article  CAS  Google Scholar 

  4. Aston-Jones, G., Shiekhattar, R., Rajkowski, J., Kubiak, P. & Akaoka, H. in The Neurobiology of Opiates (ed. Hammer, R.) 175–202 (CRC Press, Boca Raton, Florida, 1993).

    Google Scholar 

  5. Alheid, G. F., de Olmos, J. S. & Beltramino, C. A. in The Rat Nervous System 2nd edn (ed. Paxinos, G.) 495–578 (Academic, San Diego, 1995).

    Google Scholar 

  6. Brownstein, M. J. & Palkovits, M. in Handbook of Chemical Neuroanatomy, Vol. 2. Classical Transmitters in the CNS, Part 1 (eds Bjorklund, A. & Hokfelt, T.) 23–54 (Elsevier, Amsterdam, 1984).

    Google Scholar 

  7. Terenzi, M. G. & Ingram, C. D. A combined immunocytochemical and retrograde tracing study of noradrenergic connections between the caudal medulla and the bed nuclei of the stria terminalis. Brain Res. 672, 289–297 (1995).

    Article  CAS  Google Scholar 

  8. Akaoka, H., Zhu, Y., Shipley, M. T. & Aston-Jones, G. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18, 374 (1992).

    Google Scholar 

  9. Stornetta, R. L., Norton, F. E. & Guyenet, P. G. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 624, 19–28 (1993).

    Article  CAS  Google Scholar 

  10. Harris, G. & Aston-Jones, G. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology 9, 303–311 ( 1993).

    Article  CAS  Google Scholar 

  11. Fritschy, J. M., Geffard, M. & Grzanna, R. The response of noradrenergic axons to systematically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-β-hydroxylase. J. Chem. Neuroanat. 3, 309–321 ( 1990).

    CAS  PubMed  Google Scholar 

  12. Christie, M. J., Williams, J. T., Osbourne, P. B. & Bellchambers, C. E. Where is the locus of opioid withdrawal? Trends Pharmacol. Sci. 18, 134–140 ( 1997).

    Article  CAS  Google Scholar 

  13. Caille, S. et al. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J. Pharmacol. Exp. Ther. 290, 881– 892 (1999).

    CAS  PubMed  Google Scholar 

  14. Nader, K. & van der Kooy, D. Clonidine antagonizes the aversive effects of opiate withdrawal and the rewarding effects of morphine only in opiate withdrawn rats. Behav. Neurosci. 110, 389–400 (1996).

    Article  CAS  Google Scholar 

  15. Gold, M. S., Redmond, D. E. & Kleber, H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet (ii), 599–602 (1978).

    Article  Google Scholar 

  16. Roehrich, H. & Gold, M. S. Propranolol as adjunct to clonidine in opiate detoxification. Am. J. Psychiat. 144, 1099–1100 (1987).

    CAS  PubMed  Google Scholar 

  17. Grosz, H. J. Narcotic withdrawal symptoms in heroin users treated with propranolol. Lancet (ii), 564–566 ( 1972).

    Article  Google Scholar 

  18. Chieng, B. & Christie, M. J. Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci. Lett. 186, 37– 40 (1995).

    Article  CAS  Google Scholar 

  19. Britton, K. T., Svensson, T., Schwartz, J., Bloom, F. E. & Koob, G. F. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 34, 133–139 ( 1984).

    Article  CAS  Google Scholar 

  20. Blessing, W. W. The Lower Brainstem and Bodily Homeostasis (Oxford Univ. Press, New York, 1997).

    Google Scholar 

  21. Stinus, L., Le Moal, M. & Koob, G. F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37, 767–773 ( 1990).

    Article  CAS  Google Scholar 

  22. Schulteis, G., Markou, A., Gold, L. H., Stinus, L. & Koob, G. F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271, 1391–1398 (1994).

    CAS  PubMed  Google Scholar 

  23. Higgins, G. A. & Sellers, E. M. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharm. Biochem. Behav. 48, 1– 8 (1994).

    Article  CAS  Google Scholar 

  24. Pothos, E., Rada, P., Mark, G. P. & Hoebel, B. G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566, 348–350 (1991).

    Article  CAS  Google Scholar 

  25. McKittrick, C. R., Delfs, J. M., Aston-Jones, G. & Abercrombie, E. D. Differential spontaneous and withdrawal-induced efflux of catecholamines in nucleus accumbens shell of morphine-treated rats. Soc. Neurosci. Abstr. 25, 948 (1999).

    Google Scholar 

  26. Harris, G. & Aston-Jones, G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371, 155–157 ( 1994).

    Article  ADS  CAS  Google Scholar 

  27. Drolet, G., Van Bockstaele, E. J. & Aston-Jones, G. Robust enkephalin innervation of the locus coeruleus from the rostral medulla. J. Neurosci. 12 , 3162–3174 (1992).

    Article  CAS  Google Scholar 

  28. Chen, S. & Aston-Jones, G. Extensive projections from the midbrain periaqueductal gray to the caudal ventrolateral medulla: A retrograde and anterograde tracing study in the rat. Neurosci. 71, 443–459 (1996).

    Article  CAS  Google Scholar 

  29. Everitt, B. J., Robbins, T. W., Gaskin, M. & Fray, P. J. The effects of lesions to ascending noradrenergic neurons on discrimination learning and performance in the rat. Neuroscience 10, 397–410 (1983).

    Article  CAS  Google Scholar 

  30. Tejani-Butt, S. M. 3H-nisoxetine: a radioligand for quantification of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharm. Exp. Ther. 260, 427–436 ( 1992).

    CAS  Google Scholar 

Download references

Acknowledgements

We thank C. Walters and K. Altomare for technical assistance; G. Stanwood for assistance with autoradiography; and S. Aston-Jones for assistance with figures. This work was supported by the National Institute of Drug Abuse, NIH. ST-91 was generously donated by Boehringer-Ingelheim.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Aston-Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delfs, J., Zhu, Y., Druhan, J. et al. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403, 430–434 (2000). https://doi.org/10.1038/35000212

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35000212

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing